However, some clinical evidences have presented conflicting evidence, suggesting that the AEs of GLP-1 RAs may not be as severe or widespread as initially thought
You will learn the science behind the medication's half-life, the timeline for appetite changes, and how to track physiological progress before the physical results appear
The Golden Era of GLP-1 Drugs GLP-1 RAs are entero-pancreatic hormone-based treatments, first approved in 2005 for type 2 diabetes (T2D), and now commonly prescribed for weight loss and reduction of atherosclerotic cardiovascular (CV) risk in patients with T2D
The gut microbiota-bile acids-TGR5 Axis mediates Eucommia ulmoides leaf extract alleviation of injury to colonic epithelium integrity
Our comprehensive weight loss programs include: Medical evaluation and metabolic assessment to identify the best treatment approach Personalized medication selection with semaglutide, tirzepatide, and other evidence-based options Structured dose titration designed to maximize results while minimizing side effects Regular monitoring with bloodwork, body composition tracking, and clinical check-ins Nutrition and exercise guidance to optimize body composition and preserve lean mass Transition planning as new treatments like retatrutide become available Whether semaglutide, tirzepatide, or eventually retatrutide is the right fit for your goals, our team provides the medical expertise and ongoing support needed for lasting results